News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Purely Proteins Limited Announces Biomedical Collaboration With Asahi Kasei Corporation

10/19/2005 5:12:20 PM

CAMBRIDGE, England, Dec. 1 /PRNewswire/ -- Purely Proteins Ltd (Cambridge, UK) today announced the initiation of a research collaboration to discover and develop new biomedical products with Asahi-Kasei Corporation (Tokyo, Japan). Aimed at expanding Asahi's already highly successful range of bio-materials, the project will develop new methods for purifying proteins using the proprietary ligand discovery systems developed at Purely Proteins.

Commenting on the program, Purely Proteins' Chief Executive Officer, Dr David Bailey, said, "We are delighted to be working with Asahi-Kasei, a world- class chemical company with unrivalled experience of developing advanced bioprocessing materials. This project presents both companies with major new opportunities for product development in an exciting area of biotechnology."

Commenting from Asahi Kasei, External Technology Manager, Dr. Ogawa, said, "We have been very impressed with the capability of Purely Proteins' state-of- the-art science and technology. Purely Proteins' expertise in protein purification and ligand discovery will complement Asahi's in-house development programs and add significant value to our company's existing products."

Purely Proteins

Purely Proteins has been established to exploit the increasing need for and use of human proteins in human medical research. The company purifies suites of human proteins, as both drug targets and bio-therapeutics, using proprietary processes that ensure both high purity and biological activity. Purely Proteins also offers ligand screening services, backed by state-of-the- art informatics, to examine therapeutic targeting to these proteins. Further information about Purely Proteins Ltd can be found at


Originally focused on the fibers and chemicals business sectors, today Asahi Kasei is growing through diversification into the fields of housing, health care and electronics. Asahi Kasei Corporation has seven constituent corporations - Asahi Kasei Fibers, Asahi Kasei Chemicals, Asahi Kasei Life & Living, Asahi Kasei Construction Materials, Asahi Kasei Homes, Asahi Kasei EMD and Asahi Kasei Pharma. Special emphasis is placed on R&D in the fields of electronics, health care, environmental preservation, and energy conservation. Further information about the Asahi-Kasei Corporation can be found at

Purely Proteins Limited

CONTACT: Dr David Bailey, Chief Executive Officer of Purely Proteins,+44-1223-426400, Fax: +44-1223-426003,; orDr Shuichiro Ogawa, External Technology Manager, Corporate R&D, Asahi KaseiCorporation, +81-3-3507-2686, Fax: +81- 3-3507-2426,

Read at

comments powered by Disqus